Skip to main content
Original Research, Prostate Cancer, Genitourinary Cancers, Targeted Therapies
Comparing the Impact of Abiraterone and Enzalutamide Sequencing on Progression-Free Survival in Veterans with Metastatic Castration-Resistant Prostate Cancer
Nicholas J. Newman, PharmD; Sara E. Gordon, PharmD, BCOP; Charles J. Nock, MD; Christopher J. Burant, PhD; Candice M. Wenzell, PharmD, BCOP
Read More
Original Research, Adverse Events, Oral Therapy, Tyrosine Kinase Inhibitor
The Link Between Hypoalbuminemia and Oral Tyrosine Kinase Inhibitor Adverse Events in Adults with Malignant Solid Tumors
Jessica Marini, PharmD, BCOP; Bailey Bass Hammond, PharmD; Jacob Rennebaum, PharmD; Erin Weeda, PharmD, BCPS; Jagoda Misniakiewicz, PharmD; Amy Sion, PharmD, BCOP
Read More
Original Research, Adverse Events
Safety and Efficacy of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients with Cancer and Baseline Renal Dysfunction
Emily H. Hsu, PharmD, and Ryan Beechinor, PharmD, BCPS, BCOP
Read More
Lung Cancer
2022 Midyear Review: Non–Small-Cell Lung Cancer
Read More
Faculty Perspectives: Through the Pharmacists’ Lens: A Deep Dive into the Practice Dynamics in Graft-versus-Host Disease
Read More
Real-World Uptake and Utilization Patterns of Biosimilars in Clinical Practice
Lee Schwartzberg, MD, FACP, Bhavesh Shah, RPh, BCOP
Read More
Faculty Perspectives: Comprehensive Biomarker Testing in NSCLC: Opportunities to Advance Precision Medicine
Maria E. Arcila, MD, Mark A. Socinski, MD, Lauren Welch, MSN, NP-C, AOCNP
Read More
Editorial, Biosimilars
Adoption of Biosimilars—Why the Delay?
Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Read More
FDA Updates, Leukemia
Tibsovo Received a New Indication, in Combination with Azacitidine, for Newly Diagnosed Patients with AML and IDH1 Mutation
Read More
Meeting Highlights Online Only
AACR Highlights, Vaccinations, COVID-19, Infections
Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer
Read More
Page 52 of 199
Results 511 - 520 of 1986